Home Tags Takeda

Tag: Takeda

Takeda

Takeda Wants 2nd Circuit To Toss Actos Antitrust Suit

Takeda Pharmaceuticals on Wednesday, April 7, urged a federal appeals court to toss lawsuits accusing it of delaying generic versions of its blockbuster diabetes...
Takeda

Japan’s Takeda Sells $2.3B Drugs Subsidiary To Blackstone

Takeda Pharmaceutical  is selling its subsidiary in Japan focused on consumer healthcare to US investment fund Blackstone Group. The deal, announced Monday, August 24, by...
EU FLAG

EU Regulators Allow Takeda To Buy Shire

Japan’s Takeda Pharmaceutical will not be required to sell a biologic drug, a concession made to address EU antitrust concerns over its 2018 bid...
Takeda

Takeda To Divest Products To Brazil’s Hypera For $825M

Brazil’s Hypera Pharma announced on Monday, March 2, that it has signed a contract to buy a portfolio of 18 pharmaceutical products from Japan’s...

US: Takeda loses bid to DQ Baker Botts in antitrust case

Takeda Pharmaceutical Company on Thursday, June 6, lost a bid to disqualify Baker Botts from representing generic drug company Zydus Pharmaceuticals in a lawsuit...

Japan: Takeda wins shareholder approval for US$59B Shire acquisition

Takeda Pharmaceutical has won shareholder approval to finance its £46 billion (US$58.6 billion) purchase of Shire, paving the way for Japan’s largest corporate takeover...

EU: Commission approves acquisition of Shire by Takeda, subject to conditions

The European Commission has approved under the EU Merger Regulation the acquisition of Shire by Takeda Pharmaceutical Company. The decision is conditional on the...

EU: Takeda considers selling experimental drug to win EU approval

Pharmaceutical company Takeda is talking with the European Commission about selling an experimental inflammatory bowel disease drug to help close its US$62 billion takeover...

EU: EC sets date for decision on Takeda’s Shire acquisition

On Friday, September 28, the European Commission announced that it has set a deadline of November 6 for its decision on Japanese pharmaceutical company...

US: FTC clears Takeda’s proposed US$62b Shire takeover

Takeda Pharmaceutical has received US regulatory approval for its US$62 billion takeover of Irish drugmaker Shire, clearing a “significant” hurdle to completing Japan’s largest-ever...

News

Enable Notifications    OK No thanks